NumFin

Jiangsu Sihuan Bioengineering Co., Ltd

Symbol: 000518.SZ

SHZ

2.29

CNY

Market price today

  • -39.5269

    P/E Ratio

  • -12.2204

    PEG Ratio

  • 2.36B

    MRK Cap

  • 0.00%

    DIV Yield

Jiangsu Sihuan Bioengineering Co., Ltd (000518-SZ) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ). Companys revenue shows the average of 238.061 M which is 15.951 % gowth. The average gross profit for the whole period is 111.118 M which is 12.668 %. The average gross profit ratio is 0.401 %. The net income growth for the company last year performance is 0.392 % which equals -1.483 % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Jiangsu Sihuan Bioengineering Co., Ltd, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.000. In the realm of current assets, 000518.SZ clocks in at 564.82 in the reporting currency. A significant portion of these assets, precisely 28.341, is held in cash and short-term investments. This segment shows a change of -0.261% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 0.379, if any, in the reporting currency. This indicates a difference of -25.670% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 28.366 in the reporting currency. This figure signifies a year_over_year change of 0.000%. Shareholder value, as depicted by the total shareholder equity, is valued at 557.241 in the reporting currency. The year over year change in this aspect is -0.081%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 124.269, with an inventory valuation of 408.76, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 46.65. Account payables and short-term debt are 52.7 and 20.38, respectively. The total debt is 48.75, with a net debt of 20.57. Other current liabilities amount to 24.52, adding to the total liabilities of 144.58. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992

balance-sheet.row.cash-and-short-term-investments

78.5928.338.354.6
53.1
39.4
40.7
64.9
24.1
34.7
139.8
196.1
200.8
134.6
71.4
64.7
75
193.9
306.3
387.5
395.2
352.4
298.1
26.6
7.9
0.9
10.9
12.7
11
35.1
22
1.8

balance-sheet.row.short-term-investments

0.580.20.2-19.6
-20.5
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0.2
1.4
6.6
10
1.4
0.1

balance-sheet.row.net-receivables

365.54124.3147.8162.9
146.3
142.5
153.6
160.3
264.6
161.5
171.6
269.9
364.5
183
156.4
159.5
364.7
357.3
393
389
179.8
144.7
224.3
37.3
11.8
1.8
16
11.6
2.6
5.9
3.5
10.4

balance-sheet.row.inventory

1650.93408.8430.7449.1
556.5
580.6
584.1
461.6
211.9
42.3
48.2
32.8
43.1
42
191.4
59.3
143
179.8
116.7
154
165
185.1
193.2
48.3
39.6
14.6
5.9
15.2
32.8
28.8
32.5
7

balance-sheet.row.other-current-assets

7.223.43.72.3
0
0.8
-8.7
-10.9
-57.8
110
90
-42.5
-102.5
-3.5
-9.8
132.4
-101.6
-65.5
-81.8
-85.8
-4.4
-8.2
-18.7
65.2
60.4
70.2
123
93.8
81.8
84.1
79.6
34.3

balance-sheet.row.total-current-assets

2109.05564.8620.4668.9
755.9
763.4
769.8
675.9
442.8
348.6
449.6
456.4
505.9
356
409.5
416
481
665.4
734.2
844.7
735.5
674
696.9
177.3
119.7
87.5
155.8
133.3
128.2
153.8
137.5
53.6

balance-sheet.row.property-plant-equipment-net

322.5985.19284.5
80.9
89.5
79.9
241.8
304
330.2
237.3
250
247.1
251.3
266.6
269.3
317.4
420
432.9
340.3
321
294.9
231.6
74.1
71.8
65.8
72.6
105.3
73.5
90.9
83.1
59.6

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
6.3
6.3
0
0
0
12.3
48.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

138.6146.641.344
49.8
40
45.6
69.3
59.1
102
98
161.7
172.4
168.9
27.3
42.6
52.2
87.9
79.8
148.6
161.2
163
150.1
0
0
3.2
5.4
5.7
6.1
6.5
6.9
7.2

balance-sheet.row.goodwill-and-intangible-assets

138.6146.641.344
49.8
40
45.6
69.3
59.1
102
98
168
178.7
168.9
27.3
42.6
64.5
87.9
79.8
148.6
161.2
163
150.1
0
0
3.2
5.4
5.7
6.1
6.5
6.9
7.2

balance-sheet.row.long-term-investments

0.880.40.521
21.9
0
25.5
23.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25.3
0
0
0
0
0
0

balance-sheet.row.tax-assets

22.325.24.55.3
7.2
6.3
4.4
4
4.5
12.4
12
11.8
10.8
1.6
3.7
0
0
0
0
0
0
0
0
0
0
-25.3
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

132.243640.50
0.2
26.7
6.4
3.1
24.1
24.9
25.7
26.6
27.5
184.2
45.5
48.2
20.4
55.2
48.6
55.7
12.4
13.1
3.3
23.3
25.2
23.8
65.4
29.6
53.6
32
27.2
6.7

balance-sheet.row.total-non-current-assets

616.65173.3178.9154.8
160
162.5
161.8
341.5
391.7
469.5
373
456.5
464.1
606
343.2
360.1
402.3
563.1
561.2
544.6
494.7
471
385
97.4
97
92.9
143.4
140.6
133.2
129.4
117.2
73.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

2725.7738.1799.3823.7
915.8
925.9
931.6
1017.4
834.5
818.1
822.6
912.9
969.9
962
752.7
776.1
883.3
1228.5
1295.5
1389.3
1230.2
1145
1081.9
274.7
216.7
180.3
299.2
273.9
261.4
283.2
254.6
127

balance-sheet.row.account-payables

225.1152.760.857.6
63.4
60.5
19.1
313.1
84.3
25.6
14.5
17.3
13.3
13.3
14.2
7.9
11.2
25.4
92.6
127.3
26.4
21.9
16
2.5
10
16.6
2.7
11.1
0
0.1
0
0

balance-sheet.row.short-term-debt

84.1420.420.316
16
70
50
53
35
1.7
9.6
0
0
0
1.8
51.8
2
132.1
141.7
92
52
3.4
3.4
25.9
24.3
18.8
30.9
33.7
21.2
18.4
18.3
17.5

balance-sheet.row.tax-payables

24.018.86.811.4
13.1
7.2
8.7
9.1
9
5.8
6.7
14.1
13.7
7.8
3.6
-2.8
1.6
6.4
-0.7
-3.7
10.2
8.1
14.7
4.8
2
2.3
0
1
-1.3
1.3
-0.3
0.1

balance-sheet.row.long-term-debt-total

109.7628.430.835.1
0
0
0
0
0
0
1.7
0
0
0
0
0
0
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
7.5
0.3
3.5
7.3
9.9
13.3
24.7

Deferred Revenue Non Current

000.81
0
0
1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

108.2124.513.311.5
30.8
145
61.8
13.8
12.1
11.1
15.6
62
38.9
68.2
11.2
15.2
14.7
21.1
21
17.9
14.7
8.6
24.4
11.7
3.4
1.2
9.6
21.8
23.8
12.8
12
8.7

balance-sheet.row.total-non-current-liabilities

116.1128.431.61
1.7
0.4
2.2
1
16.6
4.9
6.5
3.3
1.9
0.8
0
2.6
1.7
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
7.6
0.5
3.7
7.4
9.9
13.6
33.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

109.7628.430.835.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

602.55144.6152.5138.7
255.5
283.1
256.1
406.3
225.8
96.5
91.8
82.6
54.2
82.3
40.3
83.2
49.5
217.4
292.6
282.4
134.5
82.4
98.9
69.8
59.9
76
109.3
93.4
52.4
54.6
43.9
59.4

balance-sheet.row.preferred-stock

37.86000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

4118.221029.61029.61029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
1029.6
514.8
178.7
133.7
133.7
133.7
133.7
133.7
133.7
121.6
101.3
61.3

balance-sheet.row.retained-earnings

-2421.09-546.6-497.8-463
-490.3
-504.7
-475.2
-482.5
-487
-412.5
-418.5
-347.8
-357.9
-351.9
-355.9
-379.3
-239.4
-67.8
-76.9
26.6
17.1
115.9
56.5
9.8
-35.6
-96.9
-19.1
-24.9
5.1
22.9
17.4
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

113.6538.738.738.7
38.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

183.0535.635.635.6
35.6
74.3
74.3
64.1
64.1
64.1
64.1
64.1
38.7
38.7
38.7
38.7
38.7
43.2
47.1
47.1
45.4
428.3
744.8
61.3
58.7
67.4
71.2
70.2
70.2
82.3
89.7
6.2

balance-sheet.row.total-stockholders-equity

1993.84557.2606640.8
613.5
599.2
628.6
611.1
606.6
681.1
675.1
745.8
710.4
716.4
712.4
689
828.9
1004.9
999.8
1103.3
1092.1
1059
980
204.8
156.8
104.3
185.8
179
209
226.8
208.4
67.6

balance-sheet.row.total-liabilities-and-stockholders-equity

2725.7738.1799.3823.7
915.8
925.9
931.6
1017.4
834.5
818.1
822.6
912.9
969.9
962
752.7
776.1
883.3
1228.5
1295.5
1389.3
1230.2
1145
1081.9
274.7
216.7
180.3
299.2
273.9
261.4
283.2
254.6
127

balance-sheet.row.minority-interest

129.3136.340.744.2
46.8
43.6
46.9
0
2.1
40.5
55.7
84.4
205.3
163.3
0
3.8
4.9
6.2
3.1
3.5
3.6
3.6
3
0
0
0
4.2
1.6
0
1.8
2.4
0

balance-sheet.row.total-equity

2123.14593.5646.8685
660.3
642.8
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

2725.7---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

1.30.50.71.3
1.4
1.4
25.5
23.2
0
0
0
0
0
150
0
1.4
6.5
7.5
14.8
17.7
12.4
13.1
3.1
17.6
20.2
25.5
0.2
1.4
6.6
10
1.4
0.1

balance-sheet.row.total-debt

193.948.751.116
16
70
50
53
35
1.7
11.2
0
0
0
1.8
51.8
2
132.1
141.7
92
52
3.4
3.4
25.9
24.3
26.2
31.2
37.2
28.5
28.3
31.6
42.2

balance-sheet.row.net-debt

115.8920.613-38.6
-37.1
30.6
9.3
-11.9
10.9
-33.1
-128.5
-196.1
-200.8
-134.6
-69.7
-12.9
-73
-61.8
-164.6
-295.5
-343.1
-349.1
-294.8
-0.6
16.4
25.5
20.5
25.9
24.1
3.2
11
40.5

Cash Flow Statement

The financial landscape of Jiangsu Sihuan Bioengineering Co., Ltd has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.819. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 2.58 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -8474789.500 in the reporting currency. This is a shift of -0.077 from the previous year. In the same period, the company recorded 24.75, 0, and -16, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -0.72 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 10.14, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

-59.28-53.3-38.327.7
17.5
-29.7
10.7
5.6
-112.9
-9.2
-99.5
14.5
2.5
5.7
23.3
-140.9
-178.2
6.6
-103.9
11.1
69
86.3
77.4
53
38.7
-31.2

cash-flows.row.depreciation-and-amortization

18.0824.82418.4
18.9
16.2
19
26.7
23.7
22.2
25.7
27
23.7
23.9
22.9
29.2
41
40.6
42.5
38.5
31.9
27
7.4
4.1
4.2
3.9

cash-flows.row.deferred-income-tax

0-0.70.81.9
-0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00.7-0.8-1.9
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

23.3317.92.259
9.8
20.3
-37.9
-45.2
-149.3
-32.8
-21.3
8.3
-14.9
173.1
16.5
93.2
63.2
-95.3
-8.3
-9.6
-20.8
55
-66.4
-36.2
-32.1
5.3

cash-flows.row.account-receivables

38.87-0.9-16-17.5
-51.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-15.54178.5109.7
24.1
0.3
3.2
-244.9
-181.9
5.8
-15.7
9.6
-1.1
2.1
8.8
62.7
13.6
-61.5
20.4
11
20.1
8.2
10.9
-8.6
-25.1
1.3

cash-flows.row.account-payables

02.69-35
37.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-0.70.81.9
-1
20
-41.1
199.8
32.6
-38.6
-5.5
-1.2
-13.8
171
7.7
30.5
49.6
-33.9
-28.7
-20.5
-41
46.8
-77.3
-27.6
-7
4

cash-flows.row.other-non-cash-items

21.8615.512.2-4.8
12.4
15.8
-2.6
24.4
102.3
39.9
76
4.7
8.8
28.9
-5.7
87.3
101
10.8
64.3
14
2.9
3.6
11
2.7
-7.4
17.7

cash-flows.row.net-cash-provided-by-operating-activities

3.99000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-10.1-8.5-7.7-8.7
-15.2
-6.1
-24.1
-19.2
-30.3
-111
-15.8
-62.4
-39.7
-11.2
-6.1
-13.8
-18.8
-35.3
-117.2
-103.4
-54.4
-109.6
-95.5
-12.2
0
0

cash-flows.row.acquisitions-net

000.3-0.2
0.1
0
50.4
10.7
8.4
111.1
1.3
0
-27.2
-29.8
8.3
1.9
0
0
0
118.6
0
0
106
0
0
0

cash-flows.row.purchases-of-investments

-0.30-0.30
0
-24.5
24.4
0
-110
-110
-90
0
41.5
-150
-60
-130
-2.7
0
-6.4
-6.8
0
-10
-355.1
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
23.3
2.3
0
222.9
97.3
4.7
3
111.4
15
200.6
4.6
0
0
41.9
1
0
0
0
2.8
4.7
0

cash-flows.row.other-investing-activites

-0.30-1.51
0
0
-24.1
17.8
5.6
-111
38.4
0.1
-39.7
20.8
0
10.2
10.1
6.7
-40
-103.4
0.2
6.5
-95.5
3.4
0
4.3

cash-flows.row.net-cash-used-for-investing-activites

-10.4-8.5-9.2-8
-15.1
-7.3
28.9
9.3
96.7
-123.7
-61.5
-59.3
46.2
-155.2
142.9
-127
-11.4
-28.6
-121.8
-94
-54.2
-113.1
-440.1
-6
4.7
4.2

cash-flows.row.debt-repayment

-16-16-16-16
-70
-50
-10
-35
-1.7
-9.6
-3.8
0
0
0
-227.4
0
-250
-239.6
-320
-320
-1.3
0
-86.8
0
-34.5
-11.3

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-0.76-0.7-0.7-0.5
-3.5
-2.7
-11.8
-2
-1.9
-0.5
-0.9
0
0
0
-14.7
-1.9
-4.4
-3.6
-3.8
-7.7
-34.7
-4.5
-6.8
-0.1
-0.9
-1.8

cash-flows.row.other-financing-activites

10.6810.19-73.9
44
36
-20.5
61.2
35
1.6
28.7
0
0
0
49
50
150
266.6
279.8
360
50
0
775.8
1.2
34.4
11.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-6.08-6.6-7.7-90.5
-29.5
-16.7
-42.3
24.2
31.5
-8.4
24
0
0
0
-193.2
48.1
-104.4
23.4
-44
32.3
14
-4.5
682.2
1.1
-1
-1.8

cash-flows.row.effect-of-forex-changes-on-cash

0.0500-0.3
-0.3
0.1
0
0
0
0.1
0.1
0
0
0
0
0
0
65.9
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-12.44-10.2-16.71.5
13.7
-1.3
-24.2
45.1
-8
-111.9
-56.4
-4.7
66.2
63.2
6.7
-10.3
-88.9
23.4
-171.1
-7.7
42.8
54.3
271.5
18.7
7.2
-2

cash-flows.row.cash-at-end-of-period

69.527.737.954.6
53.1
39.4
40.7
64.9
19.9
27.8
139.8
196.1
200.8
134.6
71.4
64.7
75
23.4
206.3
387.5
395.2
352.4
298.1
26.6
7.9
0.7

cash-flows.row.cash-at-beginning-of-period

81.9437.954.653.1
39.4
40.7
64.9
19.9
27.8
139.8
196.1
200.8
134.6
71.4
64.7
75
163.9
0
377.4
395.2
352.4
298.1
26.6
7.9
0.7
2.7

cash-flows.row.operating-cash-flow

3.994.90.2100.2
58.6
22.6
-10.8
11.6
-136.1
20.1
-19
54.6
20.1
231.6
57
68.7
26.9
-37.3
-5.4
54.1
82.9
171.9
29.4
23.6
3.4
-4.4

cash-flows.row.capital-expenditure

-10.1-8.5-7.7-8.7
-15.2
-6.1
-24.1
-19.2
-30.3
-111
-15.8
-62.4
-39.7
-11.2
-6.1
-13.8
-18.8
-35.3
-117.2
-103.4
-54.4
-109.6
-95.5
-12.2
0
0

cash-flows.row.free-cash-flow

-6.1-3.6-7.591.5
43.4
16.5
-34.9
-7.6
-166.4
-91
-34.8
-7.8
-19.7
220.4
50.9
54.9
8.1
-72.6
-122.7
-49.4
28.5
62.3
-66.1
11.3
3.4
-4.4

Income Statement Row

Jiangsu Sihuan Bioengineering Co., Ltd's revenue saw a change of -0.129% compared with the previous period. The gross profit of 000518.SZ is reported to be 191.9. The company's operating expenses are 230.9, showing a change of -13.465% from the last year. The expenses for depreciation and amortization are 24.75, which is a 0.152% change from the last accounting period. Operating expenses are reported to be 230.9, which shows a -13.465% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.276% year-over-year growth. The operating income is -39, which shows a 0.681% change when compared to the previous year. The change in the net income is 0.392%. The net income for the last year was -53.28.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

income-statement-row.row.total-revenue

234.8270.1351505.4
417.9
395.5
346.1
327.3
237.8
241.2
208.7
262.5
244.1
208.4
194.1
179.4
281.3
281.1
205.7
311.5
375.7
470.1
366.8
187.2
105.2
0.5
206.7
83.5
59.2
82
62.3
73.6
75.9

income-statement-row.row.cost-of-revenue

69.1678.2107.3212.9
106.9
98.4
82.8
113.2
90
98.2
103.8
134.2
126.6
110.6
111.5
179.6
236.2
201.6
171.2
221.7
243.2
330.3
239.6
120.7
73.7
0.7
186.5
94.5
60.8
73.4
53.8
0
0

income-statement-row.row.gross-profit

165.64191.9243.6292.5
311
297.1
263.2
214.1
147.8
143
104.9
128.3
117.5
97.8
82.6
-0.2
45.1
79.5
34.6
89.8
132.4
139.8
127.2
66.6
31.5
-0.2
20.3
-10.9
-1.6
8.6
8.6
73.6
75.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

30.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

32.02---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

98.76---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-2.8836.436.244.1
42
-1.5
-1.7
14.7
14.5
0.2
-2.8
3.3
1.4
16.4
0.6
9.5
-63.1
1.3
-49.9
22.7
20.1
31
0.5
5.2
23.7
-5.7
-5.2
-1.5
2.2
1.2
-0.1
0
0

income-statement-row.row.operating-expenses

199.17230.9266.8257.5
270.8
314.4
250.5
192.5
142.3
104
121.7
107.3
102.3
80.8
66.3
63.9
79.3
66.3
103.8
88.7
57
58.4
30.4
15.1
14.1
16
20.5
15.6
10.1
6.8
4.8
0
0

income-statement-row.row.cost-and-expenses

268.33309.2374.2470.4
377.7
412.7
333.3
305.7
232.3
202.3
225.5
241.5
228.9
191.3
177.8
243.5
315.5
267.9
275
310.4
300.2
388.7
270
135.8
87.9
16.7
207
110.1
70.9
80.3
58.6
0
0

income-statement-row.row.interest-income

0.050.10.10.1
0.1
0.1
0.1
0.1
0.2
0.3
0.6
0.8
0.7
0.6
0.3
0.4
1.1
1.6
2.8
3
2.3
2.4
1.2
0.1
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.880.70.70.8
3.4
2.9
1.9
13.3
5.8
4.4
6.1
0
0
0
2.1
0.1
3.6
3.5
4.7
6.2
1.6
2
2.4
1.2
2.4
3.3
-0.3
2.2
-1.7
-4.5
-3.1
0
0

income-statement-row.row.selling-and-marketing-expenses

98.76---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-26.2-14.6-12.85.1
-12.4
-13.1
4.1
-8.9
-100.9
-38.5
-77.3
0.1
-10.5
-8.3
7.8
-76.8
-144
-2.8
-35.6
-4.6
-1.7
0.2
-1
0.8
10.2
-14.7
8.5
-2.9
-4.9
17.8
20.3
-66.1
-71.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-2.8836.436.244.1
42
-1.5
-1.7
14.7
14.5
0.2
-2.8
3.3
1.4
16.4
0.6
9.5
-63.1
1.3
-49.9
22.7
20.1
31
0.5
5.2
23.7
-5.7
-5.2
-1.5
2.2
1.2
-0.1
0
0

income-statement-row.row.total-operating-expenses

-26.2-14.6-12.85.1
-12.4
-13.1
4.1
-8.9
-100.9
-38.5
-77.3
0.1
-10.5
-8.3
7.8
-76.8
-144
-2.8
-35.6
-4.6
-1.7
0.2
-1
0.8
10.2
-14.7
8.5
-2.9
-4.9
17.8
20.3
-66.1
-71.8

income-statement-row.row.interest-expense

0.880.70.70.8
3.4
2.9
1.9
13.3
5.8
4.4
6.1
0
0
0
2.1
0.1
3.6
3.5
4.7
6.2
1.6
2
2.4
1.2
2.4
3.3
-0.3
2.2
-1.7
-4.5
-3.1
0
0

income-statement-row.row.depreciation-and-amortization

16.5224.22118.4
18.9
16.2
19
26.7
23.7
22.2
25.7
27
23.7
23.9
22.9
29.2
41
40.6
42.5
38.5
31.9
27
7.4
4.1
4.2
3.9
-14.2
1.2
2.5
-17.6
-20.3
0
0

income-statement-row.row.ebitda-caps

-35.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-58.71-39-23.231.3
40.2
-28.8
18.5
-1
-108.7
1.3
-91.3
17.8
3.3
6.4
23.5
-150.4
-115.1
11.5
-53.1
20.2
96.9
113.2
95.8
56.1
26.1
-25.9
13.9
-27.8
-14.2
19.3
24.1
73.6
75.9

income-statement-row.row.income-before-tax

-61.59-53.6-3636.4
27.8
-30.3
16.8
12.8
-95.3
0.4
-94.1
21.1
4.7
8.8
24.1
-140.9
-178.2
11.5
-103.9
19.7
95.4
113.1
96
56.8
38.7
-31.2
8.5
-29.4
-14.3
20
24
7.6
4.2

income-statement-row.row.income-tax-expense

0.93-0.32.28.8
10.4
-0.6
6.2
7.2
17.6
9.6
5.4
6.6
2.2
-0.5
0.7
13.9
-67.4
4.9
-31.3
8.6
26.4
26.9
18.6
3.8
-11.1
0.3
2.7
-2
-4.8
2
3.6
1.1
0.3

income-statement-row.row.net-income

-59.28-53.3-38.327.3
14.3
-29.4
7.3
4.5
-74.4
6
-70.7
10.1
-6
7.7
23.3
-139.9
-176.8
7.2
-103.5
11.2
69
85.7
76.4
53
38.7
-31.2
5.8
-28.6
-14.3
18.4
20.4
6.4
3.8
Similar Stocks
You may also be interested in:
SRNE
Sorrento Therapeutics, Inc..
0.014 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.8 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.03 USD
NASDAQ
GUBRA.CO
Gubra A/S.
296 DKK
CPH
T5O.DE
CytoTools AG.
0.468 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.04 NOK
OSL
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.05 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Frequently Asked Question

What is Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) total assets?

Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) total assets is 738078462.000.

What is enterprise annual revenue?

The annual revenue is 111882287.000.

What is firm profit margin?

Firm profit margin is 0.705.

What is company free cash flow?

The free cash flow is -0.006.

What is enterprise net profit margin?

The net profit margin is -0.252.

What is firm total revenue?

The total revenue is -0.151.

What is Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) net profit (net income)?

The net profit (net income) is -53281016.880.

What is firm total debt?

The total debt is 48749843.000.

What is operating expences number?

The operating expences are 230901302.000.

What is company cash figure?

Enretprise cash is 16499359.000.